UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

Journal of thrombosis and haemostasis, 2015-12, Vol.13 (12), p.2187-2191

2015

Volltextzugriff (PDF)

Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis

Journal of thrombosis and haemostasis, 2017-06, Vol.15 (6), p.1142-1154

2017

Volltextzugriff (PDF)

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials

BMJ, 2011-05, Vol.342 (may24 2), p.d3036-d3036

2011

Volltextzugriff (PDF)

Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test

European heart journal, 2011-07, Vol.32 (13), p.1657-1663

2011

Volltextzugriff (PDF)

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

British journal of surgery, 2005-10, Vol.92 (10), p.1212-1220

2005

Volltextzugriff (PDF)

Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events

European heart journal, 2010-06, Vol.31 (12), p.1449-1456

2010

Volltextzugriff (PDF)

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

Journal of thrombosis and haemostasis, 2010-09, Vol.8 (9), p.1959-1965

2010

Volltextzugriff (PDF)

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

Clinical and applied thrombosis/hemostasis, 2019, Vol.25, p.1076029619883946-1076029619883946

2019

Volltextzugriff (PDF)

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

Journal of thrombosis and haemostasis, 2007-04, Vol.5 (4), p.746-753

2007

Volltextzugriff (PDF)

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1660-1665

2007

Volltextzugriff (PDF)

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?

European heart journal, 2007-07, Vol.28 (14), p.1717-1722

2007

Volltextzugriff (PDF)

Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work

Thrombosis research, 2018-10, Vol.170, p.165-174

2018

Volltextzugriff (PDF)

Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer

Journal of thrombosis and haemostasis, 2011-05, Vol.9 (5), p.1081-1083

2011

Volltextzugriff (PDF)

Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 study

The bone & joint journal, 2013-04, Vol.95-B (4), p.459-466

2013

Volltextzugriff (PDF)

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.714-721

2010

Volltextzugriff (PDF)

Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists

European journal of internal medicine, 2016-09, Vol.33, p.47-54

2016

Volltextzugriff (PDF)

Aspirin for Preventing the Recurrence of Venous Thromboembolism

The New England journal of medicine, 2012-05, Vol.366 (21), p.1959-1967

2012

Volltextzugriff (PDF)

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Journal of thrombosis and haemostasis, 2003-12, Vol.1 (12), p.2490-2496

2003

Volltextzugriff (PDF)

Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE

Journal of thrombosis and haemostasis, 2012-05, Vol.10 (5), p.822-832

2012

Volltextzugriff (PDF)

Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case–control study

Journal of neurology, neurosurgery and psychiatry, 2006-01, Vol.77 (1), p.95-97

2006

Volltextzugriff (PDF)

Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1218-1223

2005

Volltextzugriff (PDF)

Early admission to stroke unit influences clinical outcome

European journal of neurology, 2006-03, Vol.13 (3), p.250-255

2006

Volltextzugriff (PDF)

Need for extensive diagnostic work-up for patients with lacunar stroke

Journal of neurology, 2008-05, Vol.255 (5), p.637-642

2008

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(111)
Buchkapitel
(1)

Sprache

Englisch
(109)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(112)
Female
(103)
Male
(103)
Life Sciences & Biomedicine
(99)
Science & Technology
(99)
Aged
(93)
Adult
(60)
Cardiovascular System & Cardiology
(47)
Aged, 80 And Over
(46)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Hematology
(42)
Treatment Outcome
(34)
Peripheral Vascular Disease
(33)
Risk Factors
(31)
Cardiology. Vascular System
(21)
Double-Blind Method
(21)
Prospective Studies
(19)
Anticoagulants - Administration & Dosage
(18)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial

Anticoagulation in patients with isolated distal deep vein thrombosis: a meta‐analysis

Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials

Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?

Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work

Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer

Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 study

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)

Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists

Aspirin for Preventing the Recurrence of Venous Thromboembolism

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism

Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE‐HIP1, SAVE‐HIP2 and SAVE‐KNEE

Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case–control study

Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Early admission to stroke unit influences clinical outcome

Need for extensive diagnostic work-up for patients with lacunar stroke

Aktive Filter

Suchergebnisse filtern